| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-27 23:27 Tx date 2026-03-27 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,849
+2,500 vol $9.54 each |
44,678 | |
| Filed 2026-03-27 23:26 Tx date 2026-03-27 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,500
+3,000 vol $9.50 each |
42,178 | |
| Filed 2026-03-27 23:25 Tx date 2026-03-27 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,880
+2,000 vol $9.44 each |
39,178 | |
| Filed 2026-03-27 23:24 Tx date 2026-03-27 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,800
+2,000 vol $9.40 each |
37,178 | |
| Filed 2026-03-27 23:24 Tx date 2026-03-27 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,475
+2,500 vol $9.39 each |
35,178 | |
| Filed 2026-03-27 22:51 Tx date 2026-03-27 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$90,000
+30,000 vol $3.00 each |
905,012 | |
| Filed 2026-03-27 22:50 Tx date 2026-03-27 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-90,000
-30,000 vol $3.00 each |
150,000 | |
| Filed 2026-03-18 18:36 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,518
+1,700 vol $10.89 each |
337,910 | |
| Filed 2026-03-18 18:35 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,638
+1,800 vol $10.91 each |
336,210 | |
| Filed 2026-03-18 18:35 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,352
+400 vol $10.88 each |
334,410 | |
| Filed 2026-03-18 18:34 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Maya Freedman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,026
+1,929 vol $10.90 each |
38,702 | |
| Filed 2026-03-18 18:33 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Maya Freedman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,084
+1,300 vol $10.83 each |
36,773 | |
| Filed 2026-03-18 18:31 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Yale Freedman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,168
+1,800 vol $10.65 each |
36,945 | |
| Filed 2026-03-18 18:30 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Benjamin Freedman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,385
+3,874 vol $10.17 each |
37,019 | |
| Filed 2026-03-18 18:28 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45,003
+4,200 vol $10.71 each |
11,237 | |
| Filed 2026-03-18 18:23 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,533
+1,700 vol $10.90 each |
1,632,470 | |
| Filed 2026-03-18 17:49 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: PNG Enterprise Foundation (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-162,000
-15,000 vol $10.80 each |
33,725 | |
| Filed 2026-03-18 17:48 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: PNG Enterprise Foundation (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$146,175
+48,725 vol $3.00 each |
48,725 | |
| Filed 2026-03-18 17:46 Tx date 2021-03-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: PNG Enterprise Foundation (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-18 17:44 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: PNG Enterprise Foundation (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-146,175
-48,725 vol $3.00 each |
0 |